Thalassaemia trials in France

4 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 4Enrolling by invitation
  A Study to Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

  Where

  Bordeau, Créteil, Lyon, Marseille, Paris

  Age

  18 years and over

  People

  55 worldwide

  Run by

  Agios Pharmaceuticals, Inc.

  See details and how to joinNCT05777993 · EU 2026-526243-35-00
• No phaseTaking people
  Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD

  Where

  Chambéry

  Age

  18 years and over

  People

  36

  Run by

  Centre Hospitalier Metropole Savoie

  See details and how to joinNCT07207577
• Phase 3Taking people
  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Where

  Creteil, Lyon Cedex 03, Paris

  Age

  2 years and over

  People

  480 worldwide

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT06609226 · EU 2024-510805-27-00
• Phase 3Taking people
  A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

  Where

  Angers, Créteil, La Tronche, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Strasbourg, Toulouse, Tours

  Age

  18 years and over

  People

  665 worldwide

  Run by

  Celgene

  See details and how to joinNCT04064060